How biobanking supports biomedical research

One of the most valuable advances in qPCR devices is the use of panels. Instead of running separate single tests, panels allow the detection of multiple pathogens or genetic markers in one run. This provides: Time efficiency: several results from the same sample in less time Cost effectiveness: fewer reagents, consumables, and reduced workload Clinical impact: faster diagnosis and more accurate decision-making for patient care In modern healthcare, efficiency is not optional – it is essential. qPCR panels are a great #qPCR #MolecularDiagnostics #ClinicalLaboratory #RealTimePCR #MolecularBiology #Bioneer #MedicalDiagnostics #Genomics #HealthcareInnovation #LabTechnology #ClinicalResearch #DiagnosticTools #QIAGEN

🌍 Why choose μCaler? μCaler is Nanodigmbio's internationally patented hybrid capture technology, redefining sensitivity and flexibility in NGS. 💡 Unlike traditional systems with fixed ~120 nt probes, μCaler deploys 20–100 nt probes, offering: 🔬 Higher sensitivity – ideal for low-frequency variants and low-input samples. 🎯 More flexibility – adaptive probe design across complex genomic regions. ⚡ Simplified workflow – fewer manual steps, faster results. 🌐 Wide applications – from methylation & mutation co-detection to MRD monitoring and pathogen detection. With global patent protection and proven performance, μCaler stands as the next-generation standard in hybrid capture. 🔗 Learn more: https://lnkd.in/gVKTK-nc #Nanodigmbio #μCaler #HybridCapture #NGS #Innovation #Genomics #UltraSencitiveProbe #MRDmonitoring #Methylation #Mutation #MSRE #PathogenDetection

Earlier this year, Roche unveiled an entirely new class of next-generation sequencing (NGS) – sequencing by expansion (SBX) technology – and we’re excited to share an in-depth first look at an SBX dataset. Join the upcoming webinar on September 10 to dive deeper and learn how to analyze SBX-Duplex (SBX-D) data with confidence The SBX technology and analysis tools are in development and not commercially available. The content of this material reflects current study results and/or design goals. go.roche.com/sbx-d #Genomics #WeAreRoche #MakeSpaceWithSBX

💡 Beyond the Genome: Harnessing Proteomics & Metabolomics to Power Precision Medicine. At ARABLAB LIVE, I had the opportunity to share how multi-omics integration can truly drive #precision_medicine.  🚨 The right test is not always the most advanced one. It’s the test that provides an accurate, cost-effective, and practical reflection of the patient’s current state. 💡 Precision medicine is not just about technology; it’s about making the right choice at the right time. At EXPRESSMED Diagnostics & Research we are proud to have the tools and expertise to detect across #Genomics, #Proteomics, and #Metabolomics. This enables us to guide physicians toward selecting the most appropriate method for each diagnosis to ensure accurate diagnosis and better patient outcomes. #Genomics #proteomics #metabolomics #precisionmedicine #healthcare #laboratory #HealthcareInnovation #Expressmed

As part of our Analytical Instruments Market Report launch, Katie Schneider is sitting down with experts to dig deeper into the trends shaping research and clinical applications. In this session, Jake J. from University of Mississippi Medical Center shares his perspectives on the democratization of specialty instruments, the momentum behind multiomics, and how sequencing capabilities are driving outcomes in both research and clinical settings. Stay tuned for more Q&A sessions with leaders across the genomics and omics ecosystem. Explore the full Analytical Instruments Market Report and download a sample here: https://lnkd.in/gtp7_sTe #LifeSciences #Genomics #AnalyticalInstruments #Sequencing #Multiomics #DeciBio

We’ve been reconstructing dynamics from static snapshots, useful for discovery, but limited for causality. Pseudotime-based inference can miss fast, rare, or non-monotonic transitions and depends on assumptions that may not fit your system. Complement your dataset with longitudinally paired datapoints from Live-seq to observe what actually happens in the very same cell. What this unlocks: • Within-cell causality and true trajectories • Direct capture of rare states and fast switches • Less reliance on inference-heavy models If you’re studying drug resistance, differentiation, or stress responses, moving from snapshots to live-cell “movies” can turn a model into a mechanism. Our application scientists are here to help. Reach out to book a consultation or join our #webinar 👇 QR codes below. #LiveSeq101 #TemporalBiology #Genomics #LiveSeq #FluidFM #LiveSeq #SingleCell #SingleCellSequencing #SingleCellOmics #Omics #SingleCellBiology #Transcriptomics #FunctionalGenomics #Omics #NextGenSequencing #NGS #scRNAseq

We were delighted to host a webinar led by Dr. Lior Blau, featuring Dr. Pranav Patel, CEO of n6™, who presented how iconPCR™ with AutoNorm is transforming NGS workflows. The session highlighted how iconPCR addresses the biggest PCR bottleneck with real-time, per-well control – reducing library prep time by up to 60% and improving data quality, while fitting seamlessly into existing workflows. It was inspiring to learn how this innovation can make genomics faster, smarter, and more reproducible. https://lnkd.in/dw3F8_7V #NGS #Genomics #Innovation #Webinar #PCR  

Our commitment to innovation at Roche is fundamentally reshaping diagnostics – including sequencing data analysis. Our Research & Development teams are pioneering new approaches and tools that process sequencing data as it's generated, where it's generated, delivering the unprecedented combination of flexibility, efficiency and quality. This means transforming processes to significantly accelerate critical research. We are proud to drive this paradigm shift, empowering scientists to focus on breakthrough insights and unleash potential. https://lnkd.in/e3meHZFb #Genomics #NGS #MakeSpaceWithSBX #RocheSBX

Hours, not days! At ESHG 2025, Roche showed how new technology can take a whole genome sample from library prep to variant identification in under 5 hours — a process that usually takes 1–2 days. For oncology and genomics, this kind of speed means less time managing data and more time translating results into potentially clinically meaningful and impactful insights that can transform patient care. As a consultant, I help diagnostic innovators and pharma teams navigate how advances like this fit into real-world clinical practice, reimbursement, and market access strategies. For more have a look at https://lnkd.in/dd_C6_sS #precisiononcology #precisiononcologyconsulting #wgs

Yahoo Finance reports on Oryzon Genomics SA announcement of HOPE-2 PMS clinical trial and their sponsorship of CureSHANK's first-ever PMS burden of illness study. Read the full article here: https://lnkd.in/eC64szZs